Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.
BACKGROUND
High intake of folate may reduce risk for colon cancer, but the dosage and duration relations and the impact of dietary compared with supplementary sources are not well understood.


OBJECTIVE
To evaluate the relation between folate intake and incidence of colon cancer.


METHODS
Prospective cohort study.


METHODS
88,756 women from the Nurses' Health Study who were free of cancer in 1980 and provided updated assessments of diet, including multivitamin supplement use, from 1980 to 1994.


METHODS
442 women with new cases of colon cancer.


METHODS
Multivariate relative risk (RR) and 95% CIs for colon cancer in relation to energy-adjusted folate intake.


RESULTS
Higher energy-adjusted folate intake in 1980 was related to a lower risk for colon cancer (RR, 0.69 [95% CI, 0.52 to 0.93] for intake > 400 microg/d compared with intake < or = 200 microg/d) after controlling for age; family history of colorectal cancer; aspirin use; smoking; body mass; physical activity; and intakes of red meat, alcohol, methionine, and fiber. When intake of vitamins A, C, D, and E and intake of calcium were also controlled for, results were similar. Women who used multivitamins containing folic acid had no benefit with respect to colon cancer after 4 years of use (RR, 1.02) and had only nonsignificant risk reductions after 5 to 9 (RR, 0.83) or 10 to 14 years of use (RR, 0.80). After 15 years of use, however, risk was markedly lower (RR, 0.25 [CI, 0.13 to 0.51]), representing 15 instead of 68 new cases of colon cancer per 10,000 women 55 to 69 years of age. Folate from dietary sources alone was related to a modest reduction in risk for colon cancer, and the benefit of long-term multivitamin use was present across all levels of dietary intakes.


CONCLUSIONS
Long-term use of multivitamins may substantially reduce risk for colon cancer. This effect may be related to the folic acid contained in multivitamins.
Giovannucci
E
E
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Stampfer
M J
MJ
Colditz
G A
GA
Hunter
D J
DJ
Fuchs
C
C
Rosner
B A
BA
Speizer
F E
FE
Willett
W C
WC
D000328:Adult; D003110:Colonic Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D015986:Confounding Factors, Epidemiologic; D019587:Dietary Supplements; D004305:Dose-Response Relationship, Drug; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage*; D006801:Humans; D015994:Incidence; D008715:Methionine / Q000008:administration & dosage; D008875:Middle Aged; D015999:Multivariate Analysis; D011446:Prospective Studies; D012307:Risk Factors; D011795:Surveys and Questionnaires; D013997:Time Factors; D014815:Vitamins / Q000008:administration & dosage*
D014815:Vitamins; D005492:Folic Acid; D008715:Methionine